About Charles River Laboratories International, Inc. (CRL)
Charles River Laboratories International, Inc. is a Diagnostics & Research company operating in the Healthcare sector.
CRL trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap stock .
Key Statistics
- Current Price
- $359.41
- Market Cap
- $17.31B
- 52-Week High
- $379.63
- 52-Week Low
- $146.20
- Sector
- Healthcare
- Industry
- Diagnostics & Research
$1,000 Invested in Charles River Laboratories International, Inc. (CRL)
How much would $1,000 invested in CRL be worth today?
What would $1,000 invested in CRL 1 year ago be worth today?
A $1,000 investment in Charles River Laboratories International, Inc. (CRL) in 2025 would be worth $2,007 as of November 2026, representing a +100.7% total return.
What would $1,000 invested in CRL 3 years ago be worth today?
A $1,000 investment in Charles River Laboratories International, Inc. (CRL) in 2023 would be worth $2,053 as of November 2026, representing a +105.3% total return.
What would $1,000 invested in CRL 5 years ago be worth today?
A $1,000 investment in Charles River Laboratories International, Inc. (CRL) in 2021 would be worth $848 as of November 2026, representing a -15.2% total return.
What would $1,000 invested in CRL 10 years ago be worth today?
A $1,000 investment in Charles River Laboratories International, Inc. (CRL) in 2016 would be worth $4,376 as of November 2026, representing a +337.6% total return.
What would $1,000 invested in CRL at IPO be worth today?
A $1,000 investment in Charles River Laboratories International, Inc. (CRL) at IPO would be worth $16,337 as of November 2026, representing a +1533.7% total return.
Monthly Returns Heatmap
Over the past 26+ years (316 months), Charles River Laboratories International, Inc. (CRL) has averaged a monthly return of +1.37% with a median return of +1.29%. The stock had 182 positive months (58%) and 134 negative months (42%). The best month in CRL's history was July 2000 with a +36.1% return, while the worst was November 2008 at -36.4%. Historically, July tends to be the strongest month (averaging +5.1%), and April the weakest (-2.1%).
CRL's longest winning streak was 14 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2020 with a cumulative return of +56.5%, and the worst was 2008 at -71.6%.
Annual Returns
Over 26 years of trading history, Charles River Laboratories International, Inc. (CRL) has delivered an average annual return of +15.63% with a median return of +17.45%. The compound annual growth rate (CAGR) is +10.41%. The stock posted gains in 19 years (73%) and losses in 7 years (27%).
CRL's best year was 2026 with a +80.17% gain, while the worst was 2008 at -60.18%. The longest streak of consecutive positive years was 5, and the longest losing streak was 1 years. CRL achieved double-digit gains (10%+) in 14 years. It suffered double-digit losses in 5 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +80.17% | $199.48 | $359.41 |
| 2025 | +8.06% | $184.60 | $199.48 |
| 2024 | -21.91% | $236.40 | $184.60 |
| 2023 | +8.49% | $217.90 | $236.40 |
| 2022 | -42.17% | $376.78 | $217.90 |
| 2021 | +50.80% | $249.86 | $376.78 |
| 2020 | +63.56% | $152.76 | $249.86 |
| 2019 | +34.97% | $113.18 | $152.76 |
| 2018 | +3.41% | $109.45 | $113.18 |
| 2017 | +43.65% | $76.19 | $109.45 |
| 2016 | -5.22% | $80.39 | $76.19 |
| 2015 | +26.32% | $63.64 | $80.39 |
| 2014 | +19.98% | $53.04 | $63.64 |
| 2013 | +41.55% | $37.47 | $53.04 |
| 2012 | +37.10% | $27.33 | $37.47 |
| 2011 | -23.10% | $35.54 | $27.33 |
| 2010 | +5.49% | $33.69 | $35.54 |
| 2009 | +28.59% | $26.20 | $33.69 |
| 2008 | -60.18% | $65.80 | $26.20 |
| 2007 | +52.14% | $43.25 | $65.80 |
| 2006 | +2.08% | $42.37 | $43.25 |
| 2005 | -7.91% | $46.01 | $42.37 |
| 2004 | +34.02% | $34.33 | $46.01 |
| 2003 | -10.78% | $38.48 | $34.33 |
| 2002 | +14.93% | $33.48 | $38.48 |
| 2001 | +22.30% | $27.38 | $33.48 |
Frequently Asked Questions: CRL
What sector is CRL in? ▼
CRL operates in the Healthcare sector, specifically in the Diagnostics & Research industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has CRL performed historically? ▼
Over 26 years of trading history, CRL has posted gains in 19 years (73% of the time). The best year was 2026 with a +80.2% return. Past performance does not guarantee future results.
How can I invest in CRL? ▼
You can invest in CRL through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold CRL.
Last updated: 11/1/2026